Curing diffuse intrinsic pontine glioma (DIPG) remains extremely challenging, and it is considered a highly aggressive and difficult-to-treat brain tumour. As of my knowledge cutoff in September 2021, there have been no documented cases of complete and long-term cure for DIPG.
DIPG tumours are located in a critical area of the brainstem called the pons, which makes surgical removal of the tumour very challenging. Radiation therapy is the standard treatment for DIPG, but it provides only temporary relief and does not result in a cure.
Numerous research efforts and clinical trials are ongoing to explore potential treatment options for DIPG. These include targeted therapies, immunotherapies, and innovative approaches. However, these treatments are still in the experimental stage, and their effectiveness is being studied.
While there have been rare instances of children with DIPG experiencing longer-term survival or temporary responses to certain treatments, achieving a complete and long-lasting cure for DIPG remains elusive.
It's important to consult with a medical team specializing in pediatric neuro-oncology for the most up-to-date information on available treatment options, clinical trials, and supportive care measures. They can provide personalized guidance and discuss the potential benefits and limitations of various treatments for DIPG based on the specific characteristics of the tumour and the individual's situation.